comparemela.com

Latest Breaking News On - Soren lontoft hansen - Page 4 : comparemela.com

Novo Nordisk shares slip on EMA drug safety signal

COPENHAGEN, June 22 (Reuters) - Novo Nordisk said on Thursday the European Union s drug watchdog had last month raised a thyroid cancer safety signal for several of its drugs including semaglutide, the active ingredient in its popular diabe.

Alexander smithLars otto andersen langeMaggie fickNikolaj skydsgaardEli lillySoren lontoft hansenNovo nordiskEuropean medicines agencyEuropean unionOtto andersen lange

Novo Nordisk says EMA raised safety signal on drugs including semaglutide

A thyroid cancer safety signal was raised by the EU's drugs watchdog last month over several Novo Nordisk products including semaglutide, which is used in popular diabetes and obesity medicines Ozempic and Wegovy.

Nikolaj skydsgaardEli lillySoren lontoft hansenAlexander smithMaggie fickLars otto andersen langeEuropean medicines agencyThomson reuters trust principlesNovo nordiskNovo nordisk novobOtto andersen langeThomson reuters trust

Slimming drug Wegovy triggers significant forecast upgrade at Novo Nordisk

Demand for diabetes drug Ozempic, also used off label for weight loss, also fuels near doubling of sales and profit expectations

United statesSoren lontoft hansenNovo nordisk

Bavarian Nordic vows to expand monkeypox vaccine capacity

COPENHAGEN (Reuters) - Danish biotech Bavarian Nordic on Wednesday said it was making "every effort" to meet the high demand for its monkeypox vaccine.

City ofUnited kingdomPaul chaplinTerje solsvikSoren lontoft hansenJason neelyNatalie groverStine jacobsenBavarian nordic

Obesity drug supply delay not unusual says Novo Nordisk CEO

By Nikolaj Skydsgaard COPENHAGEN (Reuters) - Novo Nordisk sought to soothe concerns about supplies of its new obesity drug Wegovy on Thursday, saying .

United statesNikolaj skydsgaardSoren lontoft hansenAlexander smithLars fruergaard jorgensenNovo nordisk

vimarsana © 2020. All Rights Reserved.